Table 5. Cox regression analysis for MACE.

TZD, thiazolidinedione; SGLT-2is, sodium-glucose co-transporter 2 inhibitors; MACE, major adverse cardiovascular events; HR, hazard ratio; SBP, systolic blood pressure, LDL, low-density lipoprotein

Covariate	HR	95% CI	p-value
Group (TZD vs. SGLT-2is)	2.18	1.08-4.38	0.029
Age (years)	1.02	0.97-1.06	0.375
Sex (male)	1.15	0.62-2.11	0.659
HbA1c (%)	1.42	1.03-1.96	0.031
LDL (mg/dL)	1.01	0.99-1.02	0.137
SBP (mmHg)	1.03	1.00-1.07	0.048